Douglas E. Onsi

Biography

  Doug Onsi has been a partner at HealthCare Ventures since 2007. He was previously at Genzyme Corporation, where he served in roles as Vice President, Campath Product Operations and Portfolio Management, Oncology and as Vice President, Business Development. Prior to joining Genzyme, Doug was chief financial officer of Tolerx Inc, a HealthCare Ventures portfolio company. Before joining Tolerx, he was in business development at LeukoSite, also a HealthCare Ventures portfolio company, which was acquired by Millennium Pharmaceuticals. He began his career as an attorney at Bingham Dana LLP. Mr. Onsi is a member of the business and scientific advisory board for FastForward, a subsidiary of the National Multiple Sclerosis Society, and serves on the Cornell University Council. He received a Juris Doctor degree from the University of Michigan Law School and an undergraduate degree in biology from Cornell University.  

Research Interest

  Oncology